not tagged
immunocore
['immunocore']
news for #investors and #media: read our release announcing phase 1 data from one of our three tcr therapies in multiple types of #cancer #esmo22 #immunooncology 
A leading TCR biotechnology company focused on delivering first-in-class biological therapies. See our community guidelines: https://t.co/3GKEBGrgJd